// App-Quantinova.ai

1423 : L-Asparaginase Sensitivity and Asparagine Synthetase Expression In Primary Tumor Cells From AML Patients

Researchers

Presenter

  • Willy Berlier

Principal Investigators

  • Karine Aguera

  • Mohamed El Hamri

  • Marie-Pierre Goutagny

  • Fanny Gallix

  • Yves Bertrand

  • Xavier Thomas

  • Yann Godfrin

Medical Centers

  • Centre Hospitalier Lyon-Sud, Pierre-Benite, France

  • Centre Hospitalier Lyon-Sud, Pierre-Benite, France

  • Pediatric Hematology Department, IHOP and Claude Bernard University, Lyon, France

  • Institute of Pediatric Hematology and Oncology, Lyon Hospital, Lyon, France

Locations

  • France

Companies

  • Erytech Pharma Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Asparaginase

  • Cytarabine liposomal

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim